Crilly and colleagues investigated the cell surface expression of PAR2 on CD14+ circulating monocytes (which likely migrate into the inflamed joint and differentiate to macrophages or osteoclasts) during both RA remission and flare (17). This evidence concerns the gene CD14 and rheumatoid arthritis.